Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T22:56:21.959Z.
Calculation as of: 2026-10-06T22:56:21.959Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d814f2f9bb590440d28c37f6667649cf2cd18fb847665efd301ef7281cbad61c
PE RATIO
N/A
Market Cap
$3.00M
PE Ratio
N/A
TTM Avg
2856.01
3Y Avg
1890.61
5Y Avg
1890.61
Market Cap
$2.22M
PE Ratio
N/A
TTM Avg
201.70
3Y Avg
201.70
5Y Avg
201.70
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Top KingWin Ltd. Class A (DPU) | $2.66M | N/A | N/A | N/A | N/A |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.64M | N/A | N/A | N/A | N/A |
| Globavend Holdings Limited (GVH)vs › | $2.71M | 7.10 | 2.72 | 14.58 | 14.58 |
| Intelligent Group Limited (INTJ)vs › | $2.74M | N/A | 1.46 | 1.46 | 1.46 |
| DirectBooking Technology Co., Ltd. (ZDAI)vs › | $2.37M | N/A | N/A | N/A | N/A |
| PTL Limited (PTLE)vs › | $2.98M | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab Corp. (BGLC)vs › | $3.00M | N/A | 2856.01 | 1890.61 | 1890.61 |
| Ping An Biomedical Co., Ltd. (PASW)vs › | $2.33M | N/A | N/A | N/A | N/A |
| Professional Diversity Network, Inc. (IPDN)vs › | $2.22M | N/A | 201.70 | 201.70 | 201.70 |
| Iveda Solutions, Inc. (IVDA)vs › | $3.17M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute